2Jin Young Lee,Hye Ri Park,Yu-Kyoung Oh,Yeong-Jeon Kim,Jeehee Youn,Joong-Soo Han,Jung Mogg Kim.Effects of transcription factor activator protein-1 on interleukin-8 expression and enteritis in response to Clostridium difficile toxin A[J]. Journal of Molecular Medicine . 2007 (12)
3Therese M. Chapman,Greg L. Plosker,David P. Figgitt.Spotlight on VSL#3 Probiotic Mixture in Chronic Inflammatory Bowel Diseases[J]. BioDrugs . 2007 (1)
4Dr. Michael B. Kimmey MD,Gary W. Elmer PhD,Christina M. Surawicz MD,Lynne V. McFarland PhD.Prevention of further recurrences ofClostridium difficile colitis withSaccharomyces boulardii[J]. Digestive Diseases and Sciences . 1990 (7)
5SC Ng,AL Hart,MA Kamm,AJ Stagg,SC Knight.Mechanisms of action of probiotics: recent advances. Inflammatory Bowel Diseases . 2009
6Pothoulakis C.Review article: anti-inflammatory mechanisms of action of Saccharomyces boulardii. Alimentary Pharmacology and Therapeutics . 2009
7Galdeano CM,de Moreno de LeBlanc A,Vinderola G,Bonet ME,Perdigon G.Proposed model: mechanisms of immunomodulation induced by probiotic bacteria. Clin Vaccine Immunol . 2007
8H Kim,SH Rhee,E Kokkotou,X Na,T Savidge,MP Moyer,C Pothoulakis,JT LaMont.Clostridium difficile toxin A regulates inducible cyclooxygenase-2 and prostaglandin E2 synthesis in colonocytes via reactive oxygen species and activation of p38 MAPK. Journal of Biological Chemistry . 2005
9GO’’Callaghan,J Kelly,F Shanahan, et al.ProstaglandinE2 stimulates Fas ligand expression via the EP1 receptor in colon cancer cells. British Journal of Cancer . 2008
10Bartiett J G,et al.Treatment of antibiotic-asso-ciated Pseudomembranous Colitis. Reviews of Infectious Diseases . 1984
